These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 20071713

  • 21. Genetic testing must recognize impact of bad news on recipient.
    Kosik KS, Lopera F.
    Nature; 2008 Jul 10; 454(7201):158-9. PubMed ID: 18615057
    [No Abstract] [Full Text] [Related]

  • 22. Genetic testing for Alzheimer's disease 'not appropriate'.
    Lehrman S.
    Nature; 1997 Oct 30; 389(6654):898. PubMed ID: 9353108
    [No Abstract] [Full Text] [Related]

  • 23. Alzheimer's research. Stopping Alzheimer's before it starts.
    Miller G.
    Science; 2012 Aug 17; 337(6096):790-2. PubMed ID: 22903991
    [No Abstract] [Full Text] [Related]

  • 24. [Social and family considerations in genetic counselling].
    Svendsen MN, Koch L.
    Ugeskr Laeger; 2006 Jun 12; 168(24):2348-50. PubMed ID: 16822418
    [Abstract] [Full Text] [Related]

  • 25. Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis.
    Han SD, Bondi MW.
    Alzheimers Dement; 2008 Jul 12; 4(4):251-4. PubMed ID: 18631975
    [Abstract] [Full Text] [Related]

  • 26. Neuron-specific susceptibility to apolipoprotein E4.
    Belinson H, Dolev I, Michaelson DM.
    Neurobiol Aging; 2007 May 12; 28(5):689-92; discussion 704-6. PubMed ID: 17023093
    [No Abstract] [Full Text] [Related]

  • 27. Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer's disease susceptibility.
    Yu JT, Tan L, Ou JR, Zhu JX, Liu K, Song JH, Sun YP.
    Brain Res; 2008 May 19; 1210():216-22. PubMed ID: 18423577
    [Abstract] [Full Text] [Related]

  • 28. Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease.
    Poli M, Gatta LB, Lovati C, Mariani C, Galimberti D, Scarpini E, Biunno I, Musicco M, Dominici R, Albertini A, Finazzi D.
    Neurobiol Aging; 2008 Oct 19; 29(10):1494-501. PubMed ID: 17466415
    [Abstract] [Full Text] [Related]

  • 29. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
    Hong GS, Heun R, Jessen F, Popp J, Hentschel F, Kelemen P, Schulz A, Maier W, Kölsch H.
    Neurobiol Aging; 2009 May 19; 30(5):691-6. PubMed ID: 17904251
    [Abstract] [Full Text] [Related]

  • 30. Additional evidence for antagonistic pleiotropic effects of APOE.
    Zetterberg H, Alexander DM, Spandidos DA, Blennow K.
    Alzheimers Dement; 2009 Jan 19; 5(1):75. PubMed ID: 19118812
    [No Abstract] [Full Text] [Related]

  • 31. Gene variant linked to Alzheimer's and Parkinson's predicts diabetic neuropathy.
    Expert Rev Mol Diagn; 2002 Nov 19; 2(6):523. PubMed ID: 12465441
    [No Abstract] [Full Text] [Related]

  • 32. Early intervention in Alzheimer disease: The importance of APOE4 plus family history.
    Corder EH, Caskey J.
    Neurology; 2009 Dec 15; 73(24):2054-5. PubMed ID: 20007523
    [No Abstract] [Full Text] [Related]

  • 33. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism.
    Rodríguez-Manotas M, Amorín-Díaz M, Cañizares-Hernández F, Ruíz-Espejo F, Martínez-Vidal S, González-Sarmiento R, Martínez-Hernández P, Cabezas-Herrera J.
    Brain Res; 2007 Sep 19; 1170():119-28. PubMed ID: 17719017
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Presenilin 1 polymorphism associated with Alzheimer's disease in apolipoprotein E4 carriers.
    Martínez-García A, Aldudo J, Recuero M, Sastre I, Vilella-Cuadrada E, Rosich-Estragó M, Frank A, Valdivieso F, Bullido MJ.
    Dement Geriatr Cogn Disord; 2008 Sep 19; 26(5):440-4. PubMed ID: 18957849
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Association study of the GAB2 gene with the risk of developing Alzheimer's disease.
    Chapuis J, Hannequin D, Pasquier F, Bentham P, Brice A, Leber I, Frebourg T, Deleuze JF, Cousin E, Thaker U, Amouyel P, Mann D, Lendon C, Campion D, Lambert JC.
    Neurobiol Dis; 2008 Apr 19; 30(1):103-6. PubMed ID: 18272374
    [Abstract] [Full Text] [Related]

  • 38. Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator.
    Mutter J, Naumann J, Sadaghiani C, Schneider R, Walach H.
    Neuro Endocrinol Lett; 2004 Oct 19; 25(5):331-9. PubMed ID: 15580166
    [Abstract] [Full Text] [Related]

  • 39. Using genomic data to make indirect (and unauthorized) estimates of disease risk.
    Nyholt DR.
    Public Health Genomics; 2012 Oct 19; 15(5):303-11. PubMed ID: 22722694
    [Abstract] [Full Text] [Related]

  • 40. Genetic Risk of Alzheimer's Disease: Three Wishes Now That the Genie is Out of the Bottle.
    Frank L, Wesson Ashford J, Bayley PJ, Borson S, Buschke H, Cohen D, Cummings JL, Davies P, Dean M, Finkel SI, Hyer L, Perry G, Powers RE, Schmitt F.
    J Alzheimers Dis; 2018 Oct 19; 66(2):421-423. PubMed ID: 30282369
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.